NL162083B - Werkwijze voor de bereiding van 17alfa-mono-esters van 11beta,17alfa,21-trihydroxy-20-oxosteroiden. - Google Patents

Werkwijze voor de bereiding van 17alfa-mono-esters van 11beta,17alfa,21-trihydroxy-20-oxosteroiden.

Info

Publication number
NL162083B
NL162083B NL6901024.A NL6901024A NL162083B NL 162083 B NL162083 B NL 162083B NL 6901024 A NL6901024 A NL 6901024A NL 162083 B NL162083 B NL 162083B
Authority
NL
Netherlands
Prior art keywords
17alfa
oxosteroids
11beta
trihydroxy
preparation
Prior art date
Application number
NL6901024.A
Other languages
English (en)
Other versions
NL6901024A (nl
NL162083C (nl
Original Assignee
Koninklijke Gist Spiritus
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Koninklijke Gist Spiritus filed Critical Koninklijke Gist Spiritus
Publication of NL6901024A publication Critical patent/NL6901024A/xx
Publication of NL162083B publication Critical patent/NL162083B/nl
Application granted granted Critical
Publication of NL162083C publication Critical patent/NL162083C/nl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F21LIGHTING
    • F21VFUNCTIONAL FEATURES OR DETAILS OF LIGHTING DEVICES OR SYSTEMS THEREOF; STRUCTURAL COMBINATIONS OF LIGHTING DEVICES WITH OTHER ARTICLES, NOT OTHERWISE PROVIDED FOR
    • F21V17/00Fastening of component parts of lighting devices, e.g. shades, globes, refractors, reflectors, filters, screens, grids or protective cages
    • F21V17/10Fastening of component parts of lighting devices, e.g. shades, globes, refractors, reflectors, filters, screens, grids or protective cages characterised by specific fastening means or way of fastening
    • F21V17/20Fastening of component parts of lighting devices, e.g. shades, globes, refractors, reflectors, filters, screens, grids or protective cages characterised by specific fastening means or way of fastening by toggle-action levers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Engineering & Computer Science (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL6901024.A 1968-01-23 1969-01-22 Werkwijze voor de bereiding van 17alfa-mono-esters van 11beta,17alfa,21-trihydroxy-20-oxosteroiden. NL162083C (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB358768 1968-01-23

Publications (3)

Publication Number Publication Date
NL6901024A NL6901024A (nl) 1969-07-25
NL162083B true NL162083B (nl) 1979-11-15
NL162083C NL162083C (nl) 1980-04-15

Family

ID=9761163

Family Applications (1)

Application Number Title Priority Date Filing Date
NL6901024.A NL162083C (nl) 1968-01-23 1969-01-22 Werkwijze voor de bereiding van 17alfa-mono-esters van 11beta,17alfa,21-trihydroxy-20-oxosteroiden.

Country Status (12)

Country Link
US (1) US3557162A (nl)
AT (1) AT292929B (nl)
BE (1) BE726981A (nl)
CH (1) CH511822A (nl)
DE (1) DE1903118A1 (nl)
DK (1) DK120234B (nl)
ES (1) ES362475A1 (nl)
FR (2) FR8225M (nl)
GB (1) GB1227992A (nl)
IT (1) IT1036015B (nl)
NL (1) NL162083C (nl)
SE (1) SE339828B (nl)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1033042B (it) * 1970-03-14 1979-07-10 Luso Farmaco Inst Desametazone 17 valerato e processi per la sua preparazione
SE418294B (sv) * 1974-03-27 1981-05-18 Plurichemie Anstalt Sett att framstella en 16alfa- eller 16beta-9alfa-klor eller -fluorsteroidester
US4036831A (en) * 1975-10-28 1977-07-19 Steroid Development Company Establishment Trimethyl siloxane steroid intermediates
DE3442527A1 (de) * 1983-11-23 1985-05-30 Bösha GmbH & Co KG, 4780 Lippstadt Langfeldleuchte fuer den einsatz in schlagwetter- und explosionsgeschuetzten bereichen
US6777399B2 (en) * 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
BRPI0113042B8 (pt) 2000-08-05 2021-05-25 Glaxo Group Ltd composto da fórmula ou um seu solvato fisiologicamente aceitável, uso do mesmo, composição farmacêutica, formulação farmacêutica, método para o tratamento de um indivíduo humano ou animal com uma condição inflamatória e/ou alérgica, e, processo para preparar um composto ou um seu solvato
US6858596B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
US6759398B2 (en) * 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
GB0019172D0 (en) * 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
BR0209271A (pt) * 2001-04-30 2004-06-15 Glaxo Group Ltd Composto, uso de um composto composição farmacêutica, formulação em aerossol farmacêutica, método para o tratamento de um paciente humano ou animal com uma condição inflamatória e/ou alérgica, e, processo para a preparação de um composto
US20040248867A1 (en) * 2001-06-12 2004-12-09 Keith Biggadike Novel anti-inflammatory 17.alpha.-heterocyclic-esters of 17.beta.carbothioate androstane derivatives
US20050175545A1 (en) * 2002-02-04 2005-08-11 Keith Biggadike Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
GB0202635D0 (en) * 2002-02-05 2002-03-20 Glaxo Wellcome Mfg Pte Ltd Formulation containing novel anti-inflammatory androstane derivative
GB2389530B (en) * 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
GB0507165D0 (en) * 2005-04-08 2005-05-18 Glaxo Group Ltd Novel crystalline pharmaceutical product
GB0615108D0 (en) * 2006-07-28 2006-09-06 Glaxo Group Ltd Novel formulations
NO331891B1 (no) 2007-03-20 2012-04-30 Clavis Pharma Asa Kjemiske forbindelser, et farmasoytisk preparat inneholdende slike forbindelser, samt anvendelse derav for behandling av kreft, inflammasjon og KOLS
UA116622C2 (uk) 2011-11-11 2018-04-25 Аллерган, Інк. Похідні 4-прегенен-11ss-17-21-тріол-3,20-діону для лікування хвороб очей

Also Published As

Publication number Publication date
CH511822A (de) 1971-08-31
DE1903118A1 (de) 1969-08-07
SE339828B (nl) 1971-10-25
NL6901024A (nl) 1969-07-25
NL162083C (nl) 1980-04-15
US3557162A (en) 1971-01-19
BE726981A (nl) 1969-07-16
AT292929B (de) 1971-09-10
IT1036015B (it) 1979-10-30
FR8225M (nl) 1970-09-28
DK120234B (da) 1971-05-03
FR2000571A1 (nl) 1969-09-12
ES362475A1 (es) 1970-12-01
GB1227992A (nl) 1971-04-15

Similar Documents

Publication Publication Date Title
NL149163B (nl) Werkwijze voor de bereiding van bis-maleimiden.
NL158521B (nl) Werkwijze voor de bereiding van polypentenameren met overwegend transstructuur.
NL162083B (nl) Werkwijze voor de bereiding van 17alfa-mono-esters van 11beta,17alfa,21-trihydroxy-20-oxosteroiden.
NL159098B (nl) Werkwijze voor de bereiding van propeenoxyde.
NL149216B (nl) Werkwijze voor de bereiding van mastiek.
NL148915B (nl) Werkwijze voor de bereiding van poly-epsilon-caprolactam.
NL154490B (nl) Werkwijze voor de bereiding van p-mentheen-1-o1-4.
NL162047B (nl) Werkwijze voor de bereiding van 5-vinylnorborneen-2.
NL157052B (nl) Werkwijze voor de bereiding van kiemdodende, niet-ionogene, jodiumhoudende reinigingsmiddelen.
NL157585B (nl) Werkwijze voor de bereiding van alkylaromaten.
NL139531B (nl) Werkwijze voor de bereiding van aminoisoxazolen.
NL143210B (nl) Werkwijze voor de bereiding van hexafluorpropanol-2.
NL148583B (nl) Werkwijze voor de bereiding van cyclopentadieen uit dicyclopentadieen.
NL157894B (nl) Werkwijze voor de bereiding van azinen.
NL155006B (nl) Werkwijze voor de bereiding van beta-ionon.
NL158822B (nl) Werkwijze voor de bereiding van trans-polypentenameer.
NL161163C (nl) Werkwijze voor de bereiding van hydroxyalkylaminoalkaan- fosfonaten.
NL167406C (nl) Werkwijze voor de bereiding van l-menthol.
NL145211B (nl) Werkwijze voor de bereiding van 11-hydroxysteroiden.
NL153540B (nl) Werkwijze voor de bereiding van d-(-)-pantolacton.
NL146807B (nl) Werkwijze voor de bereiding van 2-aminopyridinen.
NL169870C (nl) Werkwijze voor de bereiding van 4-pentenalderivaten.
NL168825C (nl) Werkwijze voor de bereiding van aceetaldoxim.
NL141505B (nl) Werkwijze voor de bereiding van n-gesubstitueerde n-thioformylhydroxylaminen.
NL161744B (nl) Werkwijze voor de bereiding van lactamen.

Legal Events

Date Code Title Description
V4 Discontinued because of reaching the maximum lifetime of a patent